eloralintide vs tirzepatide 2025 ADA Highlights: A New Era for GLP-1 Therapies in Obesity and Diabetes Lilly's selective amylin agonist, eloralintide,

#SURPASSCVOT #Tirzepatide #Mounjaro #GLP1 #Type2Diabetes #CardiovascularOutcomes #PrecisionMedicine #DiabetesCare #IndiaInResearch #EASD2025 #Endocrinology #ClinicalTrials #Lilly #PrincipalInvestigator Very interesting data

There are several known side effects, including nausea, gastrointestinal distress, and in some cases, an increased risk of pancreatitis

Some patients report improvements in leg heaviness, swelling, and discomfort as they lose weight, which may reflect better circulatory function, though this evidence is largely anecdotal

Mail-order Pharmacy Fulfillment To complete the circle of care, WellSync integrates mail-order pharmacy fulfillment into the GLP-1 prescription program